Oxycodone Naloxone

DRUG2 trials

Sponsors

Mundipharma Research GmbH & Co KG, Mundipharma SAS

Conditions

ConstipationModerate to Severe Pain Due to Diabetic PolyneuropathyPain

Phase 2

A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy

CompletedNCT00944697

Mundipharma Research GmbH & Co KGModerate to Severe Pain Due to Diabetic Polyneuropathy

Start: 2009-07-31End: 2010-04-30Updated: 2012-08-17

Phase 3

Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients

TerminatedNCT01014559

Mundipharma SASConstipation, Pain

Start: 2010-02-28End: 2013-02-28Updated: 2015-09-28